Real world use of tirzepatide in the treatment of type 2 diabetes in an Arab population

Documenti analoghi

• Weight loss in people with type 1 diabetes over 12 months: Real‐world data comparing tirzepatide, semaglutide and liraglutide
  di: Ebaa Al Ozairi, et al.
  Pubblicazione: (2025)
• Real‐world evaluation of the effects of tirzepatide in patients with type 2 diabetes mellitus
  di: Michael S. Kelly, et al.
  Pubblicazione: (2024)
• Correction to “Real‐world evaluation of the effects of tirzepatide in patients with type 2 diabetes mellitus”
  Pubblicazione: (2024)
• Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes
  di: Ebaa Al‐Ozairi, et al.
  Pubblicazione: (2024)
• Real‐world impact of tirzepatide on the risk of progression to type 2 diabetes and metabolic outcomes in people with obesity and pre‐diabetes
  di: Scott A. Coon, et al.
  Pubblicazione: (2025)